Open App
Company / Corporate

Orgenesis Inc..

Follow Orgenesis Inc.

Orgenesis acquired intellectual property assets and related development product, deliverables, and data for advanced regenerative medicine therapies for spinal cord injuries.[1]

02Deals
01

Deals on Carrywatch

Every deal that names Orgenesis Inc., and its role in each.

Orgenesis Inc. / Neurocords

Orgenesis purchases assets from Neurocords

See deal details

Orgenesis Inc. / Octomera LLC

Orgenesis Inc. acquires Octomera LLC from MM OS Holdings, L.P.

See deal details
02

Deal Web

Orgenesis Inc. and 0 firms it shares a posted deal with, and the path to any other firm.

03

Financials

5 fiscal years of figures as Orgenesis Inc. reported them.

04

News

Loading headlines.

05

Sources

As of 24 Oct 2026.

  1. 01
    Form 8-K Current Report

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

  2. 02
    Agreement

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming Orgenesis Inc.:

  1. P01
  2. P02